“…Taken with permission from [83]: a [86], b [146], c [123], d [34,129], e [33], f [148], g [137], h [138], i [140], j [136], k [142], l [156], m [119], n [156], o [118], p [141], q [143], r [144], s [150], t [152], u [153], v [155], w [156], x [157]. Competitive inhibition [33] Pyranopyridine MBX3132 [131] HT within the RND transporter (T state) [34] >100 µg ml −1 [131] FQs, PIP 5ENO (MBX2319), 5ENP (MBX2931), 5ENQ (MBX3132), 5ENR (MBX3135) [34] Competitive inhibition [34] Pyridylpiperazine-based BDM88832 [148] Transmembrane domain of RND transporter (L state) [148] >500 µM >250 µM Pyridomycin 7OUK (BDM8885), 7OUL (BDM88832) [148] Allosteric inhibition [148] Antidepressant Amitriptyline [86] HT within the RND transporter (T state) [86] -CIP, NAL, norfloxacin [86] -Competitive inhibition/altered functional movements [86] Antipsychotic Chlorpromazine [86] HT within the RND transporter (T state) [86] 256 g ml −1 CIP, NAL, norfloxacin…”